Chemical Compound

VU0359595

CAS Registry Number 1246303-14-9
VU0359595 chemical structure
Primary Record

VU0359595

In stock
5,362 g
Purity
99.6 %
CAS
1246303-14-9

Compound Identifiers & Properties

CAS
1246303-14-9
PubChem CID
44573131
SMILES
C[C@@H](CN1CCC(CC1)N2C3=C(C=C(C=C3)Br)NC2=O)NC(=O)[C@@H]4C[C@H]4C5=CC=CC=C5
Canonical SMILES
C[C@@H](CN1CCC(n2c(=O)[nH]c3cc(Br)ccc32)CC1)NC(=O)[C@@H]1C[C@H]1c1ccccc1

Names & Synonyms

  • VU0359595
  • 1246303-14-9
  • CHEMBL524182
  • ML270
  • orb1704970
  • SCHEMBL10277051
  • SCHEMBL29607257
  • BDBM87119
  • AOB1035
  • cid_53470193
  • JSVNNLRZCJAYTQ-ORYQWCPZSA-N
  • DTXSID801382176
  • GLXC-02716
  • WZB30314
  • BDBM50257541
  • EX-A11064
  • ZINC40953486
  • AKOS027320660
  • NCGC00386841-03
  • NCGC00386841-04
  • VU-0359595
  • CID-53361951
  • DA-59075
  • MS-29232
  • HY-101293
  • CS-0021093
  • J3.162.442H
  • VU0359595-1
  • G14167
  • Cyclopropanecarboxamide, N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-, (1R,2R)-
  • VU0359595 (2)
  • VU0359595, >=97% (HPLC)
  • VU 0359595;VU0359595
  • (1R,2R)-N-((S)-1-(4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide
  • (1R,2R)-N-[(2S)-1-[4-(5-Bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
  • (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide
  • (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide
  • (1r,2r)-N-([s]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1h-benzo(d)imidazol-1-yl]piperidin-1-yl} propan-2-yl)-2-phenylcyclopropanecarboxamide
  • (1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide (Inh_VU0359595)
  • (1R,2R)-N-[(1S)-2-[4-(5-bromo-2-keto-3H-benzimidazol-1-yl)piperidino]-1-methyl-ethyl]-2-phenyl-cyclopropanecarboxamide;2,2,2-trifluoroacetic acid
  • (1R,2R)-N-[(2S)-1-[4-(5-bromanyl-2-oxidanylidene-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenyl-cyclopropane-1-carboxamide;2,2,2-tris(fluoranyl)ethanoic acid
  • (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
  • (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-1,3-benzodiazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide
  • (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]propan-2-yl]-2-phenyl-1-cyclopropanecarboxamide;2,2,2-trifluoroacetic acid
  • (1R,2R)-N-[(2S)-1-[4-(5-bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide;2,2,2-trifluoroacetic acid
  • (1R,2R)-N-[(S)-2-[4-(5-Bromo-2-oxo-2,3-dihydro-1H-benzoimidazole-1-yl)piperidine-1-yl]-1-methylethyl]-2-phenylcyclopropane-1-carboxamide
  • racemic trans-N-((S)-1-(4-(5-bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-phenylcyclopropanecarboxamide